Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis.
Polymyositis (PM) is an autoimmune muscle disease characterized by oligoclonal T cell infiltrates mediating myocytotoxicity. Although antigenic triggers for this process remain undefined, clinically homogeneous subsets of PM patients are characterized by autoantibodies directed against nuclear and cytoplasmic Ags that include histidyl-tRNA synthetase (Jo-1). Available evidence suggests that formation of anti-Jo-1 autoantibodies is Ag-driven and therefore dependent on CD4(+) T cells that may also direct cytolytic CD8(+) T cells involved in myocyte destruction. To assess peripheral blood T cell responses to Jo-1, we first subcloned full-length human Jo-1 as well as novel fragments of Jo-1 into the maltose-binding protein expression vector pMALc2. Expressed proteins were then used in standard proliferation assays with either PBMC or autologous DCs as sources of APCs. Although PBMC-derived APCs and DCs both supported peripheral blood T cell proliferation when primed with full-length human Jo-1, only DCs promoted proliferative responses to a unique amino-terminal fragment of Jo-1. mAb blockade of different HLA Ags revealed that these responses were MHC class II dependent. Therefore, for the first time, these studies demonstrate anti-Jo-1 T cell responses in Jo-1 Ab-positive PM patients as well as in healthy control subjects. More importantly, this work underscores the critical importance of APC type in dictating T cell responses to a novel antigenic fragment of Jo-1.
Ascherman
Dana P
DP
Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. ascher@pitt.edu
Oriss
Timothy B
TB
Oddis
Chester V
CV
Wright
Timothy M
TM
D000328:Adult; D000368:Aged; D017951:Antigen Presentation / Q000276:immunology; D000938:Antigen-Presenting Cells / Q000201:enzymology / Q000276:immunology*; D001323:Autoantibodies / Q000096:biosynthesis*; D002478:Cells, Cultured; D003001:Cloning, Molecular; D018920:Coculture Techniques; D004306:Dose-Response Relationship, Immunologic; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D005260:Female; D006681:HLA-D Antigens / Q000276:immunology / Q000502:physiology; D006643:Histidine-tRNA Ligase / Q000096:biosynthesis / Q000276:immunology* / Q000494:pharmacology; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000096:biosynthesis / Q000276:immunology* / Q000494:pharmacology; D017285:Polymyositis / Q000201:enzymology* / Q000276:immunology*; D016176:T-Lymphocyte Subsets / Q000201:enzymology* / Q000276:immunology*
D001323:Autoantibodies; D018984:Epitopes, T-Lymphocyte; D006681:HLA-D Antigens; D010446:Peptide Fragments; D006643:Histidine-tRNA Ligase